(LFCR) – Globe Newswire
-
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
-
Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
-
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
-
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating Lifecore Biomedical, Inc. on Behalf of Lifecore Stockholders and Encourages Investors to Contact the Firm
-
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
-
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
-
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
-
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
-
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
-
Lifecore Biomedical Provides Business Update
-
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
-
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
-
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
-
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
-
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
-
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
-
Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT
-
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
-
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
-
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
-
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
-
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
-
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
-
Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business
-
Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report
-
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
-
Lifecore Biomedical Raises Capital for Growth with Existing Stockholder
-
Lifecore Biomedical Announces Completion of Corporate Name Change
Back to LFCR Stock Lookup
